Sanofi beefs up diabetes pipeline to retrieve success

PARIS (Reuters) - Sanofi sees a more diversified pipeline driving a return to growth at its diabetes unit in the coming years and will consider acquisitions and partnerships to help boost performance, a company executive said on Tuesday.

Britain moves closer to legalizing medicinal use of cannabis

LONDON (Reuters) - Britain moved a step closer to legalizing the medicinal use of cannabis after a report concluded there are benefits for patients as the government reviews the rules to allow drugs derived from the banned plant.

Breast cancer surgeons don't always order genetic testing for patients

(Reuters Health) - Many breast cancer patients may miss out on genetic tests that could help pinpoint the ideal treatment regimen at least in part because their surgeons are uncomfortable discussing the pros and cons of these tests, a U.S. study suggests.

Fertility problems, reproductive technology tied to slightly more birth defects

(Reuters Health) - Women who struggle to get pregnant or use reproductive technologies like in vitro fertilization (IVF) may be more likely to have preemies and kids with birth defects than their peers who conceive without difficulty, a U.S. study suggests.

AstraZeneca wins speedy approvals for cancer drugs in Japan

LONDON (Reuters) - AstraZeneca has won rapid regulatory approval for new uses of two of its important cancer drugs in Japan, less than six months after the first global approvals in Western markets.

Trump administration names new U.S. drug enforcement chief

(Refiles this July 2 story to correct typo in name of former President George W. Bush in paragraph 7.)

Minor stroke needs quick medical attention, too

(Reuters Health) - Minor strokes and "mini-strokes," or transient ischemic attacks (TIAs), need early medical attention, just like major strokes, but a public education campaign in the UK had little success convincing the public to act fast after these events.

U.S. defibrillator probe reduced questionable implantation rate

(Reuters Health) - A U.S. government investigation of allegations that doctors were implanting heart-shocking defibrillators into patients who didn't meet federal guidelines led to a dramatic reduction in the number of implants and may have saved many patients from unnecessary surgery, researchers report in the Journal of the American Medical Association.The 2010 Department of Justice probe involved Medicare recipients, but the new research also documents a comparable drop in defibrillator usage

Drug use in Kenya's coast communities up as West-bound heroin flows through

NAIROBI (Reuters) - Heroin use is increasing in Kenya's coastal communities as international traffickers use them as a transit point for drugs bound from Afghanistan to the West, creating health and social problems, a European Union-funded report said on Tuesday.

Roche 'highly encouraged' by Tecentriq results in breast cancer

ZURICH (Reuters) - Swiss drugmaker Roche said on Monday that a trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer.

Related Videos

Machine transforms household trash into fuel

High pot taxes are a drag for Californians

You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here